Get the Stockscreener App
1.15
1.71%
-0.02
Mira Pharmaceuticals Inc stock is traded at $1.15, with a volume of 514.91K.
It is down -1.71% in the last 24 hours and down -22.82% over the past month.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.17
Open:
$1.19
24h Volume:
514.91K
Relative Volume:
0.99
Market Cap:
$19.38M
Revenue:
-
Net Income/Loss:
$-11.24M
P/E Ratio:
-1.5102
EPS:
-0.7615
Net Cash Flow:
$-4.79M
1W Performance:
-4.17%
1M Performance:
-22.82%
6M Performance:
-46.01%
1Y Performance:
+7.48%
1-Day Range:
$1.15
$1.22
1-Week Range:
$1.10
$1.22
52-Week Range:
$0.51
$5.01
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
813-369-5150
Address
1200 BRICKELL AVENUE, MIAMI
Compare MIRA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MIRA
Mira Pharmaceuticals Inc
|
1.15 | 19.38M | 0 | -11.24M | -4.79M | -0.7615 |
|
LLY
Lilly Eli Co
|
878.66 | 827.20B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
86.36 | 386.95B | 42.09B | 14.65B | 10.11B | 3.2833 |
|
JNJ
Johnson Johnson
|
153.81 | 344.63B | 88.82B | 14.07B | 19.03B | 5.79 |
|
ABBV
Abbvie Inc
|
191.41 | 341.01B | 56.33B | 4.28B | 15.62B | 2.40 |
|
MRK
Merck Co Inc
|
87.86 | 251.88B | 64.17B | 17.12B | 14.84B | 6.7297 |
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
Real-Time Update: Zebra Technologies Corp (ZBRA) Stock Navigates the Market with Up-to-Date Data - The News Heater
Monday.Com Ltd (MNDY) Shares Down Despite Recent Market Volatility - The News Heater
Mira Pharmaceuticals Inc (MIRA) Stock: Evaluating the Market Performance - The News Heater
Vanda Pharmaceuticals Inc (VNDA) Shares Rise Despite Market Challenges - The News Heater
Brazil Potash Corp (GRO) Shares Plummet Below 1-Year High - The News Heater
Report: OpenAI's ex-CTO, Mira Murati, has recruited OpenAI co-founder John Schulman - Yahoo Finance
OpenAI cofounder John Schulman is joining Mira Murati’s startup after brief stint at Anthropic - Yahoo Finance
Kernel and Mira Launch Industry’s First $300M Secured AI API - GlobeNewswire Inc.
Mira Network Launches $10M Grant Program for AI Builders - EIN News
UCalgary researchers to validate Mira Hormone Monitor - Yahoo Finance
TEVA Stock Drops Over 5% Amid Financial Struggles - GuruFocus.com
U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.18% - MSN
MIRA Pharmaceuticals Reveals Preclinical Success: Ketamir-2 Optimized for Brain Delivery, Avoiding Ketamine's Drug Resistance - ACCESS Newswire
Wealth Enhancement Advisory Services LLC Acquires 6,454 Shares of PPL Co. (NYSE:PPL) - Defense World
International Assets Investment Management LLC Invests $29,000 in MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) - Defense World
MIRA Pharmaceuticals (NASDAQ:MIRA) Shares Down 1.7% – Should You Sell? - Defense World
Wealth Enhancement Advisory Services LLC Raises Position in Trimble Inc. (NASDAQ:TRMB) - Defense World
AMRN Stock Rises Over 5% Amidst Lack of Institutional Ratings - GuruFocus.com
Here's Why We're Not Too Worried About MIRA Pharmaceuticals' (NASDAQ:MIRA) Cash Burn Situation - Yahoo Finance
Cocrystal stock plunges 40% on influenza drug update (COCP:NASDAQ) - Seeking Alpha
Traws stock plunges 43% on financing update (TRAW:NASDAQ) - Seeking Alpha
Zacks Small Cap Has Pessimistic Outlook of MIRA Q4 Earnings - Defense World
Mira Pharmaceuticals appoints new accounting firm By Investing.com - Investing.com South Africa
Mira Pharmaceuticals appoints new accounting firm - Investing.com
Why Wall Street Expects This Growth Stock To Soar 99% In 2025 - Barchart
StatementProposed Amendments To The Air Passenger Protection Regulations - Barchart
Should You Buy Joby Aviation Stock While It's Below $10? - Barchart
C3.ai Stock: Buy, Sell, Or Steer Clear? - Barchart
Is Xcel Energy Stock Underperforming The Nasdaq? - Barchart
2 Fantastic Beaten-Down Growth Stocks Down 35% And 21% To Buy - Barchart
Missed Out on Nvidia: 1 No-Brainer Artificial Intelligence (AI) Stock to Buy Before It Crushes the Market in 2025, and Beyond - Barchart
MIRA Pharmaceuticals Submits IND for Ketamir-2, Targeting Unmet Needs in Neuropathic Pain Treatment - Barchart
MIRA Pharmaceuticals Submits IND for Ketamir-2On December 19, 2024, MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) disclosed that it has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for Ketamir-2, - Defense World
Stocks In Play: Canacol Energy Ltd. - Barchart
Grain Spreads: Profit Taking Theme - Barchart
Stocks Rally On Dovish PCE Inflation Report - Barchart
The Current State Of HR Is Unacceptable - Barchart
Gilead Stock Gains 15.4% In A Year: Should You Buy, Sell Or Hold? - Barchart
Is Alexandria Real Estate Stock Underperforming The Nasdaq? - Barchart
Is W.R. Berkley Stock Outperforming The Dow? - Barchart
PayPal Rises 40% In A Year: To Buy Or Not To Buy The PYPL Stock? - Barchart
US proposes voluntary guidelines for self-driving vehicles in waning days of Biden administration - Barchart
Takeaways From The Associated Press’ Reporting On Prison Labor In Alabama - Barchart
Arabica Coffee Recovers On Weaker Dollar And Smaller Brazilian Crop - Barchart
Medtronic Stock Declines 5.6% In A Month: Time To Buy The Dip? - Barchart
Is PPG Industries Stock Underperforming The S&P 500? - Barchart
Stocks Regain Footing On Dovish PCE Inflation Report - Barchart
Enterprise Products Stock Rises 25% YTD: Should You Buy Now Or Avoid It? - Barchart
Three Reasons Why PESI Is Risky And One Stock To Buy Instead - Barchart
SCARBOROUGH INNOVATES PARTNERS WITH SUNRAY VENTURE CAPITAL TO ACCELERATE LOCAL STARTUPS WITH 'CATALYST IGNITE' - Barchart
Knightscope K7 Alpha Testing Underway And 2024 Recap - Barchart
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
Mira Pharmaceuticals Inc Stock (MIRA) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Aminov Erez | Chief Executive Officer |
Nov 20 '24 |
Sale |
1.27 |
44,590 |
56,629 |
1,061,200 |
1.25%
0.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):